Head of Early Assets, Hematology
AstraZeneca
About this role
Head of Early Assets, Hematology at AstraZeneca will operate at the commercial–R&D interface to shape the early hematology pipeline from preclinical through early clinical development, ensuring line-of-sight to patient impact and long-term commercial value across modalities. The role sits on the Oncology Business Unit Leadership Team reporting to the VP, Global Head, Hematology Franchise & Cell Therapy and partners broadly across R&D, Commercial, Medical, Market Access, and external stakeholders. Based in Gaithersburg, MD; full-time.
Skills
Qualifications
About AstraZeneca
astrazeneca.comDigital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
About AstraZeneca
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for AstraZeneca.
Salary
$270k – $405k
per year
More jobs at AstraZeneca
Similar Jobs
Therapeutic Area Strategy Director, Oncology & Hematology
Novartis
Therapeutic Area Strategy Director, Oncology & Hematology
Novartis
Associate Director, Hematology, Strategic Forecasting & Portfolio Analytics
CSL
Therapeutic Area Strategy Director, Oncology & Hematology
Diversity Employment
Physician - Section Head of Pediatric Hematology/Oncology
Ochsner Health
Therapeutic Area Strategy Director, Oncology & Hematology
Diversity Employment